| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,077 |
5,536 |
$1.17M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,537 |
1,108 |
$1.04M |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,601 |
1,083 |
$562K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
6,333 |
1,285 |
$544K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,380 |
2,259 |
$522K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
798 |
519 |
$504K |
| 80053 |
Comprehensive metabolic panel |
44,234 |
22,149 |
$500K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,208 |
3,389 |
$435K |
| 80061 |
Lipid panel |
12,914 |
9,398 |
$321K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,459 |
19,811 |
$283K |
| G0378 |
Hospital observation service, per hour |
1,020 |
660 |
$272K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,662 |
7,279 |
$267K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,485 |
3,669 |
$224K |
| 80306 |
|
4,149 |
2,903 |
$208K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,896 |
2,706 |
$195K |
| 84484 |
|
4,523 |
2,441 |
$180K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,941 |
1,631 |
$174K |
| 71045 |
Radiologic examination, chest; single view |
3,529 |
2,391 |
$171K |
| 71046 |
Radiologic examination, chest; 2 views |
2,479 |
1,859 |
$164K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,896 |
1,022 |
$161K |
| 87428 |
|
3,040 |
2,049 |
$144K |
| 36000 |
|
3,502 |
1,316 |
$143K |
| 81001 |
|
7,895 |
5,713 |
$141K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
8,404 |
6,184 |
$141K |
| 81025 |
|
2,221 |
1,696 |
$140K |
| 83690 |
|
4,607 |
3,099 |
$137K |
| 84439 |
|
5,186 |
3,876 |
$136K |
| 82607 |
|
3,069 |
2,126 |
$110K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,283 |
2,645 |
$97K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
5,437 |
3,821 |
$96K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,823 |
510 |
$93K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
824 |
370 |
$90K |
| 36415 |
Collection of venous blood by venipuncture |
19,224 |
10,336 |
$89K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,086 |
942 |
$87K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,591 |
1,032 |
$86K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,403 |
1,175 |
$84K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
9,674 |
4,245 |
$82K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
436 |
332 |
$71K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,001 |
764 |
$67K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
907 |
261 |
$61K |
| 87070 |
|
1,208 |
754 |
$54K |
| 83540 |
|
2,102 |
1,486 |
$53K |
| 83605 |
|
1,463 |
803 |
$52K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,037 |
302 |
$51K |
| 83880 |
|
1,828 |
1,092 |
$50K |
| 94762 |
|
1,605 |
1,184 |
$47K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
590 |
503 |
$46K |
| 94664 |
|
1,473 |
956 |
$45K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,719 |
1,559 |
$45K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,061 |
628 |
$44K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,529 |
1,470 |
$43K |
| 82043 |
|
1,796 |
1,126 |
$41K |
| 85379 |
|
874 |
615 |
$38K |
| 87186 |
|
2,329 |
1,684 |
$33K |
| 82150 |
|
1,325 |
986 |
$33K |
| 86141 |
|
1,150 |
701 |
$32K |
| 84481 |
|
151 |
129 |
$31K |
| 80076 |
|
1,628 |
1,069 |
$25K |
| 83735 |
|
2,356 |
1,542 |
$24K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
1,589 |
737 |
$23K |
| 85610 |
|
2,927 |
1,890 |
$21K |
| 87077 |
|
4,176 |
2,228 |
$20K |
| 84703 |
|
220 |
180 |
$19K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
147 |
100 |
$18K |
| 73630 |
|
221 |
172 |
$17K |
| 87040 |
|
261 |
159 |
$17K |
| 85730 |
|
637 |
481 |
$14K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
135 |
84 |
$14K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
278 |
81 |
$12K |
| 82553 |
|
291 |
196 |
$12K |
| 73610 |
|
162 |
107 |
$12K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,341 |
2,424 |
$11K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
70 |
48 |
$11K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,560 |
763 |
$11K |
| 73030 |
|
150 |
120 |
$11K |
| 86140 |
|
311 |
276 |
$11K |
| 82550 |
|
370 |
258 |
$10K |
| 84480 |
|
197 |
164 |
$10K |
| 97161 |
|
160 |
105 |
$10K |
| 72100 |
|
90 |
80 |
$10K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,834 |
2,134 |
$9K |
| 85027 |
|
282 |
237 |
$8K |
| 83874 |
|
166 |
133 |
$8K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
215 |
185 |
$7K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
28 |
14 |
$7K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,181 |
2,171 |
$6K |
| 82962 |
|
577 |
156 |
$6K |
| 73130 |
|
60 |
52 |
$5K |
| 82803 |
|
32 |
30 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
133 |
108 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
202 |
191 |
$4K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
86 |
56 |
$4K |
| 85652 |
|
209 |
136 |
$4K |
| E0440 |
Stationary liquid oxygen system, purchase; includes use of reservoir, contents indicator, regulator, flowmeter, humidifier, nebulizer, cannula or mask, and tubing |
115 |
93 |
$4K |
| 82746 |
|
92 |
58 |
$4K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
908 |
547 |
$3K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
42 |
40 |
$3K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
170 |
140 |
$3K |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
4,309 |
897 |
$3K |
| 73560 |
|
51 |
42 |
$3K |
| 82728 |
|
51 |
38 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
861 |
653 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
301 |
237 |
$3K |
| 80074 |
|
41 |
25 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
107 |
103 |
$3K |
| 84145 |
|
58 |
40 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
162 |
36 |
$3K |
| 76536 |
|
13 |
12 |
$2K |
| 84436 |
|
28 |
26 |
$2K |
| 82948 |
|
414 |
90 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,365 |
444 |
$2K |
| 87807 |
|
55 |
32 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
21 |
13 |
$2K |
| 82570 |
|
133 |
96 |
$2K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
192 |
116 |
$2K |
| 84591 |
|
61 |
51 |
$1K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
21 |
20 |
$1K |
| 73110 |
|
12 |
12 |
$1K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
622 |
184 |
$1K |
| 97164 |
|
23 |
12 |
$1K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
63 |
40 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
26 |
26 |
$1K |
| 0031A |
|
71 |
43 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
405 |
219 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
191 |
159 |
$1K |
| 86800 |
|
13 |
13 |
$1K |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,353 |
322 |
$1K |
| J3490 |
Unclassified drugs |
495 |
193 |
$1K |
| 86308 |
|
27 |
25 |
$939.42 |
| 85007 |
|
155 |
126 |
$616.55 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
309 |
245 |
$395.49 |
| 90715 |
|
19 |
14 |
$336.96 |
| 84550 |
|
14 |
13 |
$286.98 |
| J7050 |
Infusion, normal saline solution, 250 cc |
245 |
114 |
$216.26 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
180 |
120 |
$214.13 |
| 83550 |
|
40 |
19 |
$201.24 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
199 |
152 |
$128.35 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
23 |
13 |
$120.51 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
24 |
12 |
$106.43 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
32 |
25 |
$100.45 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
19 |
13 |
$99.33 |
| S0028 |
Injection, famotidine, 20 mg |
94 |
54 |
$90.48 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
72 |
42 |
$90.03 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
38 |
26 |
$84.96 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
30 |
16 |
$47.76 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
16 |
13 |
$16.08 |